Pradžia › Opinis kolitas
Opinis kolitas klinikiniai tyrimai JAV ieško dalyvių
79 tyrimai dėl Opinis kolitas ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- New York City, NY23 tyrimai
- Orlando, FL22 tyrimai
- Miami, FL21 tyrimas
- Houston, TX17 tyrimai
- San Antonio, TX16 tyrimai
- Tacoma, WA15 tyrimai
- Chicago, IL15 tyrimai
- San Diego, CA15 tyrimai
- Tyler, TX14 tyrimai
- Colorado Springs, CO14 tyrimai
- Los Angeles, CA13 tyrimai
- St. Louis, MO13 tyrimai
- Washington, DC12 tyrimai
- Boston, MA11 tyrimai
- Providence, RI11 tyrimai
- Cincinnati, OH11 tyrimai
- Louisville, KY10 tyrimai
- Parma, OH10 tyrimai
- Lewisville, TX10 tyrimai
- Durham, NC10 tyrimai
- Lubbock, TX9 tyrimai
- Tampa, FL9 tyrimai
- Evanston, IL9 tyrimai
- Atlanta, GA9 tyrimai
- Baltimore, MD8 tyrimai
- Mountain View, CA8 tyrimai
- Garland, TX8 tyrimai
- Memphis, TN8 tyrimai
- Round Rock, TX8 tyrimai
- Scottsdale, AZ8 tyrimai
- Dallas, TX8 tyrimai
- Metairie, LA8 tyrimai
- Cleveland, OH8 tyrimai
- Seattle, WA8 tyrimai
- Pittsburgh, PA7 tyrimai
- Waukegan, IL7 tyrimai
- Fort Worth, TX7 tyrimai
- Charlotte, NC7 tyrimai
- Anaheim, CA7 tyrimai
- Wyoming, MI7 tyrimai
Pagal valstiją
- Aidahas4 tyrimai
- Alabama7 tyrimai
- Arizona19 tyrimai
- Arkansas4 tyrimai
- Džordžija14 tyrimai
- Florida31 tyrimas
- Ilinoisas24 tyrimai
- Indianas10 tyrimai
- Kalifornija39 tyrimai
- Kanzasas10 tyrimai
- Kentukis13 tyrimai
- Koloradas17 tyrimai
- Kolumbijos apskritis3 tyrimai
- Konektikutas11 tyrimai
- Luiziana15 tyrimai
- Masčusetsas16 tyrimai
- Merilendas13 tyrimai
- Minesota8 tyrimai
- Misisipė6 tyrimai
- Misūris16 tyrimai
- Mičiganas17 tyrimai
- Naujoji Hampšyras5 tyrimai
- Nevada6 tyrimai
- New Jersey7 tyrimai
- New York30 tyrimai
- North Carolina23 tyrimai
- Ohio26 tyrimai
- Oklahoma4 tyrimai
- Oregon5 tyrimai
- Pennsylvania12 tyrimai
- Rhode Island11 tyrimai
- South Carolina12 tyrimai
- South Dakota4 tyrimai
- Tennessee12 tyrimai
- Texas33 tyrimai
- Utah7 tyrimai
- Virginia14 tyrimai
- Washington22 tyrimai
- Wisconsin4 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07619547Aquamin® for Prevention of Ulcerative Colitis J-Pouch-associate Intestinal Inflammation
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07501078Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Renkami dalyviai3 fazė
Visi amžiai · Visoms lytims · Atnaujinta 2026-10-02 · NCT06651281Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Renkami dalyviai4 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Renkami dalyviai3 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-09-30 · NCT07071519Confirmatory Clinical Study in Active Ulcerative Colitis
Renkami dalyviai2 fazė
Amžius 16 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07296315A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Renkami dalyviai1/2 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-29 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-29 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-29 · NCT07845487A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-28 · NCT07463183A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT06979336Immune Regulation in Ulcerative Colitis or Crohn s Disease
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
1 Day – 75 Years · Visoms lytims · Atnaujinta 2026-09-28 · NCT00001184A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT07196748A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Renkami dalyviai3 fazė
Amžius 3 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT06663332A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Renkami dalyviai2/3 fazė
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Renkami dalyviai3 fazė
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Renkami dalyviai1 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT03816345LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07186101A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
Renkami dalyviai3 fazė
Amžius nuo 2 iki 19 · Visoms lytims · Atnaujinta 2026-09-22 · NCT04844606LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Renkami dalyviai4 fazė
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-21 · NCT06095128Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-21 · NCT07513181Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.